AzTrials
AzTrials

Bone DiseasesCleverBonesNCT06745791

Clinical Validation of BoneMRI in the Spine

An observational study of Bone Diseases and Image, run by MRIguidance B.V. at 10 sites in 4 countries.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

BoneMRI is a quantitative 3D MRI technique that has been developed recently by MRIGuidance BV©, which is based on a multiple gradient-echo sequence and a machine learning processing pipeline. Read more about this study

Who is it for?
Ages 12 years and older
Conditions the study is for
Bone Diseases, Image, Medical Device
What is being tested?
BoneMRI
Type of treatment
Medical device
How many people
450 participants
Where
10 sitesin 4 countries
Study dates
20 Aug 2021to 31 Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Subjects referred to the radiology department for an MRI and CT scan of the spine having symptoms related to a spine disorder with suspected underlying involvement of osseous structures, will be asked to participate in this study.

Who may be able to join

  • ≥ 12 years old
  • Indication for diagnostic MRI of the spine
  • Indication for diagnostic CT of the spine
  • Eligible for MRI
  • Eligible for CT
  • Written informed consent

Who cannot join

  • Pregnancy
  • History of (psychiatric) disorder which causes the patient to be incompetent to make a thought-out decision
  • claustrophobia
  • >3 months between CT and MRI scan

Trial locations and contacts

10 sites in 4 countries. Contact the study team or a site near you to ask about taking part.

Peter R Seevinck, dr. ir. contact

00316 81741711

peter.seevinck@mriguidance.com

Hilde Geraedts, phd contact

clinical@mriguidance.com

10 sites in 4 countries

Netherlands5 sites, 5 recruiting
  • Amsterdam UMC

    Amsterdam, 1105AZ

    M Maas, Prof. MD. PhD, m.maas@amsterdamumc.nl

    Recruiting
  • Leids universitair medisch center

    Leiden, 2333ZA

    K van Langevelde, Dr., K.van_Langevelde@lumc.nl

    Not yet recruiting
  • Erasmus MC

    Rotterdam, 3015 GD

    E HG Oei, Prof. Dr., e.oei@erasmusmc.nl

    Recruiting
  • Elisabeth Tweesteden Ziekenhuis

    Tilburg, 5022GC

    Ruth Geuze, Dr., r.geuze@etz.nl

    Recruiting
  • UMC Utrecht

    Utrecht, Utrecht, 3584 CX

    P R Seevinck, Dr. Ir, p.seevinck@umcutrecht.nl

    Recruiting

Other trials in Netherlands

Belgium3 sites
  • UZ Gent

    Ghent, 9000

    Completed
  • UZ Leuven

    Leuven, 3000

    Completed
  • VITAZ

    Sint-Niklaas, 9100

    Completed

Other trials in Belgium

France1 site
  • Hopital saint joseph

    Marseille, 13008

    Completed

Other trials in France

Switzerland1 site
  • Kantonsspital st. gallen

    Sankt Gallen, 9007

    Completed

Other trials in Switzerland

About this study

BoneMRI is a quantitative 3D MRI technique that has been developed recently by MRIGuidance BV©, which is based on a multiple gradient-echo sequence and a machine learning processing pipeline. The BoneMRI technology is capable of generating CT-like, quantitative radiodensity bone MRI images to visualize cortical and trabecular bone, allowing to assess bone structure and morphology, in addition to regular clinical MRI images. The use of BoneMRI has been investigated and clinically validated in multiple musculoskeletal studies involving the cervical spine, hip and sacro-iliac joint. In order to clinically use BoneMRI in the entire spine, the BoneMRI technology needs to be validated in that area as well, focussing on geometrical and voxelwise accuracy of the radiodensity contrast to assure accurate visualization of the osseous structures. As robustness against expected data variability between hospitals is crucial for successful machine learning algorithms, multiple MR field strengths and scanner types from different manufacturers will be included in this study. If successful, BoneMRI will facilitate a better, easier and cheaper workflow by enabling diagnosis, treatment planning and surgical navigation using a single radiological examination, without the potential hazards of ionizing radiation.

Read the detailed description

Rationale: BoneMRI is a quantitative 3D MRI technique that has been developed recently by MRIGuidance BV©, which is based on a multiple gradient-echo sequence and a machine learning processing pipeline. The BoneMRI technology is capable of generating CT-like, quantitative radiodensity bone MRI images to visualize cortical and trabecular bone, allowing to assess bone structure and morphology, in addition to regular clinical MRI images. The use of BoneMRI has been investigated and clinically validated in multiple musculoskeletal studies involving the cervical spine, hip and sacro-iliac joint. In order to clinically use BoneMRI in the entire spine, the BoneMRI technology needs to be validated in that area as well, focussing on geometrical and voxelwise accuracy of the radiodensity contrast to assure accurate visualization of the osseous structures. As robustness against expected data variability between hospitals is crucial for successful machine learning algorithms, multiple MR field strengths and scanner types from different manufacturers will be included in this study. If successful, BoneMRI will facilitate a better, easier and cheaper workflow by enabling diagnosis, treatment planning and surgical navigation using a single radiological examination, without the potential hazards of ionizing radiation.

Primary objective: The primary objective of this study is to investigate the performance of BoneMRI in terms of geometrical accurate visualization of the spinal osseous structures by radiodensity reconstruction when exposed to clinically relevant data variability.

Study design: This study is a prospective multi-center clinical validation study, following a comparative design.

Study population: Subjects referred to the radiology department for an MRI and CT scan of the spine having symptoms related to a spine disorder with suspected underlying involvement of osseous structures, will be asked to participate in this study.

Duration of the study: Expectation is that it will take approximately 36-48 months to include 50 patients per center.

Main study parameters/endpoints: Geometric accuracy in terms of visualization of the 3D osseous morphology of the spinal column.

Nature and extent of the burden and risk associated with participation, benefit and group relatedness: The patient does not benefit from participating in this study and will receive routine care, which includes undergoing an MRI and CT scan. For research purposes an additional MRI sequence will be obtained for each patient. The CT scan is part of routine clinical care, so patients do not receive additional ionizing radiation compared to standard care. The subjects will in no way be exposed to BoneMRI as BoneMRI will not be installed at the investigation site and will not be part of the clinical workflow, nor the BoneMRI reconstructions will be part of the patient's file or decision making process of the healthcare professional. Therefore, there are no additional risks for the patients when participating in this study. This study may contribute to lower radiation doses in future patients when concluded that BoneMRI accurately visualizes the 3D morphology of the spinal osseous structures. This would render an additional conventional CT scan redundant.

Being tested
BoneMRI
Keywords
medical device, software, synthetic CT, MRI sequence
Medical subject headings
Bone Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BoneMRIDevice

    BoneMRI is a quantitative 3D MRI technique,capable of generating CT-like, quantitative radiodensity bone MRI images to visualize cortical and trabecular bone, allowing to assess bone structure and morphology, in addition to regular clinical MRI images.

Study groups in NCT06745791
Study groupRoleWhat they receive
Spinal MRI and CTSubjects referred to the radiology department for an MRI and CT scan of the spine having symptoms related to a spine disorder with suspected underlying involvement of osseous structures, will be asked to participate in this study.
Receives: Device: BoneMRI

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Accuracy of the BoneMRI image reconstructions in terms of tissue radiodensity and tissue radiodensity contrast (in HU), and 3D morphology (in mm)

    The relevant outcome parameters defined for the BoneMRI application are related to the accurate reconstructions of tissue radiodensity, tissue radiodensity contrast and 3D morphology. The outcomes of geometrical (mm) and voxelwise (HU) accuracy of the radiodensity contrast assure accurate visualization of the osseous structures, in terms of visualization of the 3D osseous morphology of the spinal column.

    The following outcome parameters for BoneMRI are therefore defined:

    • Accuracy of the reconstruction of radiodensity and radiodensity contrast in Hounsfield Units (HU).
    • Accuracy of the 3D morphology of osseous structures in mm.

    Measured: Expected duration: approximately 36-48 months to include 50 patients per MRI configuration.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Dec 2024
  2. Study start20 Aug 2021
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
450 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06745791
Sponsor's protocol ID
CIP 005 spine multicenter
Acronym
CleverBones
Status last verified
Oct 2026
First submitted
30 Apr 2024
Last updated
7 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Bone Diseases and Image, run by MRIguidance B.V. at 10 sites in 4 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 7 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 10 sites in Netherlands, Belgium, France, Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Peter R Seevinck, dr. ir. (00316 81741711, peter.seevinck@mriguidance.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Accuracy of the BoneMRI image reconstructions in terms of tissue radiodensity and tissue radiodensity contrast (in HU), and 3D morphology (in mm) (time frame: Expected duration: approximately 36-48 months to include 50 patients per MRI configuration.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in